No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma

Authors

Tristan E. Knight, Seattle Children's Hospital, Seattle, WA
Kwang Woo Ahn, Medical College of Wisconsin, Milwaukee, WI
Kyle M. Hebert, Medical College of Wisconsin, Milwaukee, WI
Rasha Atshan, Medical College of Wisconsin, Milwaukee, WI
Donna A. Wall, University of Toronto, Toronto, ON
Kanhatai Chiengthong, Chulalongkorn University, Bangkok, Thailand
Troy C. Lund, University of Minnesota, Minneapolis, MN
Tim Prestidge, Starship Children's Hospital, Auckland, New Zealand
Hemalatha G. Rangarajan, Nationwide Children's Hospital, Columbus, OH
Christopher C. Dvorak, University of California San Francisco, San Francisco, CA
Jeffery J. Auletta, National Marrow Donor Program/Be The Match, Minneapolis, MN
Michael Kent, Atrium Health Levine Children's, Charlotte, NC
Hasan Hashem, King Hussein Cancer Center, Amman, Jordan
Julie-An Talano, Medical College of Wisconsin, Milwaukee, WI
Seth J. Rotz, Cleveland Clinic, Cleveland, OH
Ellen Fraint, The Children's Hospital at Montefiore, Bronx, NY
Kasiani C. Myers, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Wing Leung, Duke-NUS Medical School, Singapore, Singapore
Akshay Sharma, St. Jude Children's Research Hospital, Memphis, TN
Neel S. Bhatt, University of Washington School of Medicine, Seattle, WA
Timothy A. Driscoll, Duke University Pediatric Transplantation and Cellular Therapy, Durham, NC
Lolie C. Yu, LSU Health Sciences Center - New OrleansFollow
Kirk R. Schultz, The University of British Columbia, Vancouver, BC, Canada
Muna Qayed, Emory University and Children's Healthcare of Atlanta, Atlanta, GA
Larisa Broglie, Medical College of Wisconsin, Milwaukee, WI
Mary Eapen, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
Gregory A. Yanik, University of Michigan Medical Center, Ann Arbor, MI

Document Type

Letter to the Editor

Publication Date

9-4-2023

Publication Title

Bone Marrow Transplantation

First Page

1390

Last Page

1393

PubMed ID

37666957

Volume

58

Issue

12

Recommended Citation

Knight, Tristan E.; Ahn, Kwang Woo; Hebert, Kyle M.; Atshan, Rasha; Wall, Donna A.; Chiengthong, Kanhatai; Lund, Troy C.; Prestidge, Tim; Rangarajan, Hemalatha G.; Dvorak, Christopher C.; Auletta, Jeffery J.; Kent, Michael; Hashem, Hasan; Talano, Julie-An; Rotz, Seth J.; Fraint, Ellen; Myers, Kasiani C.; Leung, Wing; Sharma, Akshay; Bhatt, Neel S.; Driscoll, Timothy A.; Yu, Lolie C.; Schultz, Kirk R.; Qayed, Muna; Broglie, Larisa; Eapen, Mary; and Yanik, Gregory A., "No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma" (2023). School of Medicine Faculty Publications. 2142.
https://digitalscholar.lsuhsc.edu/som_facpubs/2142
10.1038/s41409-023-02092-3